D. E. Shaw & Co., Inc. Burning Rock Biotech LTD Transaction History

D. E. Shaw & Co., Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.16 - $3.47 $18,576 - $29,842	-8,600 Reduced 29.73%	20,329 $57,000
Q4 2022 Feb 14, 2023	SELL	$1.73 - $2.95 $14,933 - $25,464	-8,632 Reduced 22.98%	28,929 $65,000
Q3 2022 Nov 14, 2022	SELL	$2.39 - $3.96 $358,447 - $593,912	-149,978 Reduced 79.97%	37,561 $90,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $328,193 - $1.96 Million	187,539 New	187,539 $546,000
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $391,901 - $712,321	-41,559 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $721,879 - $1.16 Million	41,559 New	41,559 $743,000
Q2 2021 Aug 16, 2021	SELL	$26.14 - $37.45 $326,410 - $467,638	-12,487 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$23.5 - $39.58 $293,444 - $494,235	12,487 New	12,487 $336,000
Q4 2020 Feb 16, 2021	SELL	$22.55 - $30.87 $240,766 - $329,598	-10,677 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$19.07 - $29.61 $203,610 - $316,145	10,677 New	10,677 $268,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $716M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.